Levi & Korsinsky, LLP announces that a CODX class action lawsuit has been filed on behalf of investors who purchased Co-Diagnostics, Inc.  (CODX) This lawsuit is on behalf of a class of all persons and entities who purchased the publicly traded securities of Co-Dx during the period of May 12, 2022, through the close of the market on August 11, 2022 (4:00 p.m. ET). For more on the CODX Lawsuit please contact us today.

According to the Co-Dx lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) demand for the Company’s Logix Smart COVID-19 test had plummeted throughout the quarter ended June 30, 2022, and (ii) as a result, defendants’ positive statements about the demand for its Logix Smart COVID-19 test lacked a reasonable basis.

TO LEARN MORE ABOUT THE CODX CLASS ACTION LAWSUIT, CLICK HERE

If you suffered a loss in Co-Dx you have until October 17, 2022, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com